Durability of Response in Metastatic Melanoma Patients after Combined Treatment with Radiation Therapy and Ipilimumab

Quaovi H. Sodji, Paulina M. Gutkin, Susan M. Swetter, Sunil Arani Reddy, Susan M. Hiniker, Susan Jane Knox
ISSN / E-ISSN
— / —
DOI
10.2217/mmt-2019-0020 ↗
Volume · Issue · Pages
7 · 1 · MMT36-MMT36
Publisher
Future Medicine Ltd.
Article URL
https://doi.org/10.2217/mmt-2019-0020 ↗
Article details
Unverified
Publication date (each date has its type and source)
12 Feb 2020
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date12 Feb 2020 OpenAlex

Keywords (as given): metastatic melanoma; ipilimumab; radiotherapy; combination immunotherapy; complete response; partial response; durability of response; hypophysitis; pembrolizumab; long-term follow-up; hepatocellular carcinoma

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Melanoma Management
Publication date used
12 Feb 2020 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.